A prospective multicenter assessor blinded pilot study using confocal laser endomicroscopy for intraoperative brain tumor diagnosis

• Published in: Scientific reports Vol. 14; no. 1; pp. 6784 - 13
• Main Authors: Byun, Yoon Hwan, Won, Jae-Kyung, Hong, Duk Hyun, Kang, Ho, Kim, Jang Hun, Yu, Mi Ok, Kim, Min-Sung, Kim, Yong Hwy, Park, Kyung-Jae, Jeong, Min-Jae, Hwang, Kyungmin, Kong, Doo-Sik, Park, Chul-Kee, Kang, Shin-Hyuk
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 21.03.2024; Nature Portfolio
• Subjects: Biopsy; Brain cancer; Brain Neoplasms - diagnostic imaging; Brain Neoplasms - surgery; Brain tumors; Diagnosis; Humans; Lasers; Microscopy, Confocal - methods; Neuroimaging; Patients; Pilot Projects; Prospective Studies; Sample preparation
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-024-52494-6

In this multi-center, assessor-blinded pilot study, the diagnostic efficacy of cCeLL-Ex vivo, a second-generation confocal laser endomicroscopy (CLE), was compared against the gold standard frozen section analysis for intraoperative brain tumor diagnosis. The study was conducted across three tertiary medical institutions in the Republic of Korea. Biopsy samples from newly diagnosed brain tumor patients were categorized based on location and divided for permanent section analysis, frozen section analysis, and cCeLL-Ex vivo imaging. Of the 74 samples from 55 patients, the majority were from the tumor core (74.3%). cCeLL-Ex vivo exhibited a relatively higher diagnostic accuracy (89.2%) than frozen section analysis (86.5%), with both methods showing a sensitivity of 92.2%. cCeLL-Ex vivo also demonstrated higher specificity (70% vs. 50%), positive predictive value (PPV) (95.2% vs. 92.2%), and negative predictive value (NPV) (58.3% vs. 50%). Furthermore, the time from sample preparation to diagnosis was notably shorter with cCeLL-Ex vivo (13 min 17 s) compared to frozen section analysis (28 min 28 s) (p-value < 0.005). These findings underscore cCeLL-Ex vivo's potential as a supplementary tool for intraoperative brain tumor diagnosis, with future studies anticipated to further validate its clinical utility.